Adopting Site Quality Management to Optimize Risk-Based Monitoring
|
|
- Osborne Jordan
- 8 years ago
- Views:
Transcription
1 Adopting Site Quality Management to Optimize Risk-Based Monitoring Medidata and other marks used herein are trademarks of Medidata Solutions, Inc. All other trademarks are the property of their respective owners. Copyright 2013 Medidata Solutions, Inc.
2 2 Introduction As it is now well documented, clinical R&D organizations have been actively embarking on a paradigm shift in their approach to ensuring quality in the conduct of clinical trials. In particular, a more targeted, risk-based approach to site monitoring and data cleaning is being actively pursued by organizations both large and small. The primary goals of this new paradigm include significant improvements in resource efficiency associated with clinical R&D, increased quality in trial conduct and corresponding data, and the maintenance or even reduction of clinical trial timelines. While the interest in this paradigm has increased steadily in recent years, progress had been significantly impeded by the following factors: Lack of full electronic data capture (EDC) adoption, which severely hampers an organization s ability to proactively assess quality across all sites in a clinical trial. Concern over the potential of increased regulatory scrutiny, especially in the absence of clear guidance or endorsement for risk-based approaches from the FDA or EMA. Potential for actual decreased trial and data quality, due to less intensive on-site monitoring during trial conduct. The first of these issues has been largely overcome, as EDC and similar clinical technologies have become business as usual for most clinical R&D organizations over the past six or more years. The second issue was also finally addressed last August in the form of the FDA s draft guidance on risk-based monitoring, followed closely by EMA s reflection paper on risk-based quality management in clinical trials. These documents not only provide the industry guidance on how to approach a risk-based monitoring program, they firmly endorse the concept. The following from the FDA guidance clearly demonstrates this: FDA encourages greater reliance on centralized monitoring practices than has been the case historically, with correspondingly less emphasis on on-site monitoring. 1 The following will help you understand the challenges faced when implementing risk-based monitoring and how developing a site quality management program especially one leveraging real-time site quality analytics can simplify the adoption of this strategy.
3 3 The Role of Data Quality and Metrics in the Adoption of For many organizations, the final concern regarding potential impact on data quality has remained. Medidata has asked one question in this regard: to what extent is patient electronic case report form (ecrf) data actually corrected during trials, as a result of all of the intense scrutiny traditionally applied to that data by study teams in the form of 100 percent source document verification (SDV), extensive data management reviews and safety/medical reviews? In order to assess this, Medidata computed the following two measures using the Medidata Insights metrics warehouse, comprising over 2,500 studies from 65 contributing sponsor organizations: Total Data Correction Rate: The total percentage of ecrf data found to have one or more updates ( corrections ) following initial submission of the ecrf form. Post-Capture Data Correction Rate: The total percentage of ecrf data found to have one or more updates following the initial capture session at the site, defined as a four-hour window following initial submission of each ecrf form. The surprisingly low industry median for these two measures is illustrated in Figure 1. The total data correction rate comes in at just 4.3 percent, while the post-capture data correction rate is only 2.7 percent. Putting this in context, the post-capture rate indicates that greater than 97 percent of ecrf data is already in its final form ready for formal reporting, analysis and submission before any site monitor, data manager or other sponsor representative has had a chance to scrutinize the data! Figure 1: ecrf data correction rates 5.0% 4.32% 4.0% 3.0% 2.68% 2.0% 1.0% Total Post-Capture Source: Medidata Insights metrics warehouse
4 4 It is relevant to note that these metrics currently account for any updates to data values in the EDC audit trail, which includes natural patient event-based updates, such as adverse event (AE) resolution/outcome information that do not represent actual corrections. While Medidata has not yet filtered out these type of updates from the metric, initial analysis of AE and concomitant medication forms on various studies reveals a very high correction rate on these resolution data fields (e.g., AE resolution date, ConMed Stop Date, etc.), typically over 20 percent. Removal of these fields from the calculation will likely yield a significantly lower post-capture data correction rate, perhaps as low as two percent overall. Whatever the final figure, it s clear that our industry is spending a tremendous amount of resource effort for a very modest return, in terms of impact on the final clinical trial dataset. Figure 2 illustrates that a very typical breakdown of clinical trial costs and site monitoring in particular is one of the two largest cost drivers at 30 percent or more. If nothing else, the very modest ROI with traditional site monitoring methods should compel us to seek a more effective, efficient approach to ensuring clinical data quality. Figure 2: Clinical trial cost breakdown Site Payments Other IVRS and Drug Distribution Project and Clinical Leadership Data Management and Statistics Monitoring Source: Medidata internal analysis
5 5 The Impact of Regulatory Guidance on Site Management The FDA draft guidance identifies two key monitoring approaches that comprise an effective risk-based approach: on-site monitoring and centralized monitoring. On-site monitoring is the current de-facto practice, so the introduction of centralized monitoring now becomes a key enabler to realizing greater overall quality and resource efficiency in the new paradigm. But what exactly is centralized monitoring or more to the point what should it be? The FDA draft guidance outlines the primary goals of centralized monitoring that should guide a solution. Among them are the following: Target on-site monitoring by identifying higher risk clinical sites (e.g., sites with data anomalies or a higher frequency of errors, protocol violations or dropouts relative to other sites) Augment on-site monitoring by performing monitoring activities that can only be accomplished using centralized processes (e.g., statistical analyses to identify data trends not easily detected by on-site monitoring) Conduct aggregate statistical analyses of study data to identify sites that are outliers relative to others and to evaluate individual subject data for plausibility and completeness Conduct analyses of site characteristics, performance metrics (e.g., high screen failure rates, high frequency of eligibility violations, and delays in reporting data), and clinical data to identify trial sites with characteristics correlated with poor performance or noncompliance 2 The items above all reflect a similar theme that calls for leveraging the clinical and operational data captured through EDC and other electronic systems. Together, these can help sponsors identify sites with emerging quality-related risks, relative to other sites in the trial. This in turn enables the attention of a sponsor team s finite resources to be directed to those sites with emerging risks as proactively as possible to remediate any issues, thereby ensuring optimal quality across the trial. Any implementation of centralized monitoring should therefore include an effective signal detection system that emphasizes earliest possible detection of emerging quality-related risks at one or more trial sites.
6 6 Identification of the quality measures to use for signal detection should of course be driven by the key risk areas identified in the monitoring plan for each study. However, it is very important to note that the vast majority of trials will share similar key risk categories including the following: Patient safety monitoring and reporting, for example AEs and serious AEs (SAEs), Patient data quality, and Protocol compliance, including eligibility criteria, and visit and dosing schedules. Key Metrics to Consider for Adopting Centralized Monitoring As such, the industry can and should identify a relatively small set of measures that serve as effective surrogates for the quality of trial conduct by sites in each of these categories. As an example, one might consider the following measures related to the quality of patient ecrf data capture at each site, all of which should be readily computable using available EDC-based information: Data correction rate (percent of data corrected after initial entry) Rate of ecrf queries from clinical data management Rate of ecrf queries and/or SDV findings from site monitors Rate of auto queries (i.e., queries resulting from programmed data checks within the EDC system) Cycle time from patient visit to entry of ecrf data by the site Cycle time for sites to respond to queries from the sponsor team All of the above measures relate to processes that may have a real impact on the quality of ecrf data. One approach might be to compute all of these measures in parallel to help detect sites with emerging issues. This may have some degree of success; however, it will more likely lead to a proliferation of signal-detection noise that will actually detract from the goal of finding the true high-risk sites. Rather, we should ask which groups of measures are descriptive of the same site process and then choose the one or two that enable the most proactive and effective assessment of site quality around that process. With respect to data quality, for example, it is fair to say that ecrf query rates (e.g., auto queries, data management queries, site monitor queries, etc.) and data correction rates should all be good indicators of the level of quality with which sites are capturing patient data into the sponsor s EDC system.
7 7 In order to confirm this, Medidata conducted an analysis of these measures across over 2,000 studies in the Medidata Insights metrics warehouse, which reveals a very strong correlation between each of these query rates and data correction rates. So it holds that any one of these measures should be a sufficient surrogate to detect data quality issues. However, one of them auto query rate is clearly the most effective when viewed from the perspective of early signal detection. This is because, unlike manually generated queries and subsequent data corrections, auto queries are generated and observable immediately upon entry of the ecrf data at the site. Therefore, both the numerator and denominator comprising an auto query rate are always current, whereas the numerator in the other rates always lags behind the denominator by weeks or months (and yes, even years of delay in query generation have been observed!). Thus auto query rate is likely to be not only sufficient to detect potential data quality issues at sites, but also the most effective among the obvious choices. Note that the Visit-to-eCRF Entry cycle time metric while it does overlap with auto query rate as a surrogate for data quality also measures an additional aspect of site behavior that is worth observing. In particular, lack of timely attention to capture of patient data in the sponsor s EDC system and slowness in responding to sponsor queries may portend broader issues with site s attentiveness to and engagement with the trial overall. Additionally, various sponsor reviews of incoming EDC data begin losing their value the longer the delay in getting access to that data. So these cycle times provide an important complement and addition to the auto query rate. Understanding a Typical Site Quality Management Scenario It is indeed important to assess all potential site quality measures in the context of not only how effectively, but how proactively, they are able to support signal detection. Getting to a relatively small, focused set of standard quality measures is critical to a successful centralized monitoring implementation. From a tool perspective, organizations and study teams should be looking for a centralized dashboard in which these quality measures are pre-computed across all sites and that provides for each site a measure-by-measure and overall assessment of risk-level with respect to quality. The tool should be configured in a way that directs study team members quickly and effectively to sites with the highest risk levels requiring follow-up. Figure 3 depicts what the tool might display for a given site and measure. In the conceptual example, the AE rate for the study overall is 8.7 AEs per subject-year, and for site 105 it is 5.6, which puts that site at an elevated (yellow) risk level for potentially under-reporting AEs.
8 8 Figure 3: Example site and study AE rate scorecard Site 105 AE Rate Study AE Rate Note that this would not mean conclusively that the site is under-reporting AEs only that it is at an elevated risk of such. The study team would be responsible for deciding what, if anything, is the appropriate course of action to address this observation. It could be as simple as having the site monitor take some extra time at the next site visit to scrutinize the site s AE reporting process and perhaps to review AE reporting requirements with the site staff. It could also include increasing the amount of SDV targeted for patients enrolled at that site particularly for the AE forms. Or it could be a combination of the above. Either way, with a site quality management program, sponsors could better anticipate such risks and identify the root causes more quickly. Implementing a Site Quality Management Program About Medidata Medidata Solutions is the leading global provider of cloud-based solutions for clinical research in life sciences, transforming clinical development through its advanced applications and intelligent data analytics. The Medidata Clinical Cloud brings new levels of productivity and quality to the clinical testing of promising medical treatments, from study design and planning through execution, management and reporting. We are committed to advancing the competitive and scientific goals of global customers, which include over 90% of the top 25 global pharmaceutical companies; innovative biotech, diagnostic and device firms; leading academic medical centers; and contract research organizations. info@mdsol.com mdsol.com Using a standard set of measures, this type of centralized dashboard could be deployed very quickly for each new study a critical requirement given the importance of early issue detection during trial conduct. Organizations should also plan to employ a dashboard tool that is turnkey: not only easy to deploy for each study but also with site quality metrics automatically assessed and presented in a near real-time fashion. Such a centralized monitoring tool is not only ideal but quite feasible, and will help your organization revolutionize the way total quality is managed in clinical research. For more information on how Medidata Solutions can help you fully realize the benefits of centralized and risk-based monitoring by leveraging the site quality management concepts in this paper, please contact your Medidata representative. Medidata Clinical Cloud Cloud-based clinical research solutions Innovative technology Data-driven analytics Reduced costs Improved time to market Faster decisions Minimized risk
9 9 Endnotes 1. AUG-2011 FDA Draft Guidance: Guidance for Industry: Oversight of Clinical Investigations A Risk-Based Approach to Monitoring 2. Ibid
Why Monitoring Is More Than Just SDV
Why Monitoring Is More Than Just SDV Medidata and other marks used herein are trademarks of Medidata Solutions, Inc. All other trademarks are the property of their respective owners. Copyright 2013 Medidata
More informationRisk based monitoring using integrated clinical development platform
Risk based monitoring using integrated clinical development platform Authors Sita Rama Swamy Peddiboyina Dr. Shailesh Vijay Joshi 1 Abstract Post FDA s final guidance on Risk Based Monitoring, Industry
More informationthrough advances in risk-based
Insight brief Quintiles is a market leader with >100 risk-based monitoring studies Quintiles developed solutions that bring as much as 25% cost reduction over traditional trial execution approaches Transform
More informationAvg cost of a complex trial $100mn. Avg cost per patient for a Phase III Study
1 Industry Perspective Over the last several years, clinical research costs have sky rocketed while new drug approvals are at multi-year lows. Studies have become global in nature and more complex to manage
More informationINSERT COMPANY LOGO HERE BEST PRACTICES RESEARCH
INSERT COMPANY LOGO HERE BEST PRACTICES RESEARCH Background and Company Performance Industry Challenges esource: Electronic Clinical Trial Solution Clinical trial sponsors and clinical research organizations
More informationMonitoring Clinical Trials with a SAS Risk-Based Approach
Paper DH05 Monitoring Clinical Trials with a SAS Risk-Based Approach Laurie Rose, SAS, Cary, NC USA ABSTRACT With global regulatory encouragement, the life sciences industry is gaining momentum to embrace
More informationCLINICAL DATA MONITORING PLAN (CDMoP) PROTOCOL # [0000] [TITLE]
CLINICAL DATA MONITORING PLAN (CDMoP) PROTOCOL # [0000] [TITLE] CONTRACT RESEARCH ORGANIZATION SPONSOR [NAME] [ADDRESS] 1 TABLE OF CONTENTS 1. Purpose 3 2. References 3 3. Study Roles and Responsibilities
More informationTransforming CliniCal Trials: The ability to aggregate and Visualize Data Efficiently to make impactful Decisions
: The ability to aggregate and Visualize Data Efficiently to make impactful Decisions www.eclinicalsol.com White Paper Table of Contents Maximizing Your EDC Investment... 3 Emerging Trends in Data Collection...
More informationAn information platform that delivers clinical studies better, faster, safer and more cost effectively
An information platform that delivers clinical studies better, faster, safer and more cost effectively Powering Process & Performance Proactively manage study start-up and execution Risk profile new sites
More informationTechnology and Expertise Add Operational Value to Medical Device Trials
Technology and Expertise Add Operational Value to Medical Device Trials Copyright 2015 Medidata Solutions. Medidata Solutions and other trademarks reserved in the US and globally. Medidata and other marks
More informationSite monitoring Transformed forever?
Site monitoring Transformed forever? June 2015 www.algorics.com Introduction: As the industry implementation of Risk Based Monitoring (RBM) progresses, one area to receive less focus than most has been
More informationQUALITY CONTROL AND QUALITY ASSURANCE IN CLINICAL RESEARCH
QUALITY CONTROL AND QUALITY ASSURANCE IN CLINICAL RESEARCH Martin Valania, Executive Director, Corporate QA and Compliance Introduction Pharmaceutical companies recognize the benefits of carefully managing
More informationAn Introduction to Electronic Data Capture Software. Learn the basics to find the right system for your needs
An Introduction to Electronic Data Capture Software Learn the basics to find the right system for your needs By Forte Research Systems Software to fit your clinical research needs Cloud-based clinical
More informationWhite Paper January 2009. Top Ten Reports in Clinical Performance Management
White Paper January 2009 Top Ten Reports in Clinical Performance Management 2 Contents 3 The solution Clinical Performance Management Clinical Trail Resource Planning Reports Report #1 Clinical Trial Project
More informationInnovative Solutions Designed to Improve Operational Capacity, Efficiency and Effectiveness in Clinical Monitoring
Innovative Solutions Designed to Improve Operational Capacity, Efficiency and Effectiveness in Clinical Monitoring Brett Barber, Sr. Director, Strategic Resourcing Nicole Baker, Sr. Director, Strategic
More informationWHITE PAPER Risk, Cost and Quality: Key Factors for Outsourcing QA and Testing
WHITE PAPER Risk, Cost and Quality: Key Factors for Outsourcing QA and Testing In association with: TCS Marianne Kolding December 2012 Ed Cordin IDC OPINION IDC EMEA, 389 Chiswick High Road, London, W4
More informationWelcome to the training on the TransCelerate approach to Risk-Based Monitoring. This course will take you through five modules of information to
Welcome to the training on the TransCelerate approach to Risk-Based Monitoring. This course will take you through five modules of information to introduce you to the concepts behind risk-based monitoring,
More informationCentralized vs Onsite Monitoring:
Centralized vs Onsite Monitoring: A Sponsor s Balancing Act Applying a Risk-based Approach Introduction Since the August 2011 release of the draft guidance document by FDA on a risk-based approach to monitoring
More informationDeveloping a Strategy to Optimize Clinical Trial Supplies
Developing a Strategy to Optimize Clinical Trial Supplies Medidata and other marks used herein are trademarks of Medidata Solutions, Inc. All other trademarks are the property of their respective owners.
More informationAligning Quality Management Processes to Compliance Goals
Aligning Quality Management Processes to Compliance Goals MetricStream.com Smart Consulting Group Joint Webinar February 23 rd 2012 Nigel J. Smart, Ph.D. Smart Consulting Group 20 E. Market Street West
More informationTransforming study start-up for optimal results
Insight brief Transforming study start-up for optimal results A holistic, data-driven approach integrating technology, insights and proven processes to position clinical trials for ultimate success Up
More informationManaging and Integrating Clinical Trial Data: A Challenge for Pharma and their CRO Partners
Managing and Integrating Clinical Trial Data: A Challenge for Pharma and their CRO Partners Within the Pharmaceutical Industry, nothing is more fundamental to business success than bringing drugs and medical
More informationBringing Order to Your Clinical Data Making it Manageable and Meaningful
CLINICAL DATA MANAGEMENT Bringing Order to Your Clinical Data Making it Manageable and Meaningful eclinicalsol.com DATA IS SIMPLY BEAUTIFUL DATA STACKS IN STANDARD FORMATION This imaginative visual suggests
More informationBeyond SDV: Enabling Holistic, Strategic Risk-Based Monitoring
Beyond SDV: Enabling Holistic, Strategic Risk-Based Monitoring How Oracle Health Sciences Integrated Clinical R&D Cloud Platform Supports Risk-Based Monitoring Best Practices O R A C L E W H I T E P A
More informationSection 1 Project Management, Project Communication/Process Design, Mgmt, Documentation, Definition & Scope /CRO-Sponsor Partnership
Section 1 Project Management, Project Communication/Process Design, Mgmt, Documentation, Definition & Scope /CRO-Sponsor Partnership PROJECT MANAGEMENT - SCOPE DEFINITION AND MANAGEMENT Understands the
More informationCLINICAL DEVELOPMENT OPTIMIZATION
PAREXEL CLINICAL RESEARCH SERVICES CLINICAL DEVELOPMENT OPTIMIZATION Enhancing the clinical development process to achieve optimal results ADVANCED TECHNOLOGY COMBINED WITH INTELLIGENT THINKING CAN HELP
More informationWITH AGILE TECHNOLOGY
FUTURE-PROOF BANKING STRATEGIES Technology Transformation STARTS NOW Banks now better understand the strategic nature of their core systems and are ready to embark on critical technology projects to support
More informationFull-Service EDC as an Alternative to Outsourcing
Full-Service EDC as an Alternative to Outsourcing The lifeblood of the entire drug development process is information. Of that information, some of the most challenging, expensive, and unpredictable information
More informationProduct Lifecycle Management in the Medical Device Industry. An Oracle White Paper Updated January 2008
Product Lifecycle Management in the Medical Device Industry An Oracle White Paper Updated January 2008 Product Lifecycle Management in the Medical Device Industry PLM technology ensures FDA compliance
More informationIT Audit Perspective on Continuous Auditing/ Continuous Monitoring KPMG LLP
IT Audit Perspective on Continuous Auditing/ Continuous Monitoring KPMG LLP IT Audit Perspective on Continuous Auditing/Continuous Monitoring INTRODUCTION New demands from the board, senior organizational
More informationData Management: Good Team Work is de sleutel tot succes!
Data Management: Good Team Work is de sleutel tot succes! Gerald Ruiter Senior Data Manager Topics Introduction Data Management Activities People Process Technology Clinical Data Management: introduction
More informationRBM as Competitive Advantage for Mid-sized CROs
RBM as Competitive Advantage for Mid-sized CROs Cyntegrity s White Paper Applying RBM analytics to improve patient safety and preventive care Table of Contents Introduction...3 What is Data-driven RBM?...4
More informationClinical TOTAL CLINICAL THE COMPLETE CLINICAL CLOUD. Clinical on the Cloud. Total. Clinical Data Management. Operations. Clinical
Powe r i n g C l i n i c a l D eve l o p m e n t f r o m C o n c e p t t o C o m m e r c i a l S u c c e s s Data on CLINICAL RESEARCH SUCCESS Company efforts to speed development, boost success rates,
More informationBUILDING QUALITY INTO CLINICAL TRIALS AN FDA PERSPECTIVE
BUILDING QUALITY INTO CLINICAL TRIALS AN FDA PERSPECTIVE Jean Toth-Allen, Ph.D. Biophysicist Office of Good Clinical Practice Office of the Commissioner May 14, 2012 1 Overview I. Background why we are
More informationBarnett International and CHI's Inaugural Clinical Trial Oversight Summit June 4-7, 2012 Omni Parker House Boston, MA
Barnett International and CHI's Inaugural Clinical Trial Oversight Summit June 4-7, 2012 Omni Parker House Boston, MA This presentation is the property of DynPort Vaccine Company LLC, a CSC company, and
More informationIntegrated Clinical Data with Oracle Life Sciences Applications. An Oracle White Paper October 2006
Integrated Clinical Data with Oracle Life Sciences Applications An Oracle White Paper October 2006 Integrated Clinical Data with Oracle Life Sciences Applications EXECUTIVE OVERVIEW Even the largest pharmaceutical
More informationHow Industry Can Partner with FDA in Defining a Risk- Based Monitoring Program
How Industry Can Partner with FDA in Defining a Risk- Based Monitoring Program Presenter: Jan Holladay Pierre, MPH Quality Principal Leader DynPort Vaccine Company LLC, A CSC Company This presentation
More informationGuidance for Industry. Q10 Pharmaceutical Quality System
Guidance for Industry Q10 Pharmaceutical Quality System U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER) Center for Biologics Evaluation
More informationClinical Trial Management Software
Clinical Trial Management Software For single-site and multi-site organizations, Maptrial is a cloud-hosted clinical trial management system (CTMS) designed to track the operational data of clinical trials
More informationWhat is Clinical Data Management
What is Clinical Data Management Clinical Data Management is involved in all aspects of processing the clinical data, working with a range of computer applications, database systems to support collection,
More informationInfoset builds software and services to advantage business operations and improve patient s life
Infoset builds software and services to advantage business operations and improve patient s life Clinical Data Management ecrf & EDC Patient Support Programs Medication Adherence Mobile e-health Big Data
More informationOPTIMUS SBR. Optimizing Results with Business Intelligence Governance CHOICE TOOLS. PRECISION AIM. BOLD ATTITUDE.
OPTIMUS SBR CHOICE TOOLS. PRECISION AIM. BOLD ATTITUDE. Optimizing Results with Business Intelligence Governance This paper investigates the importance of establishing a robust Business Intelligence (BI)
More informationPharmaSUG 2016 Paper IB10
ABSTRACT PharmaSUG 2016 Paper IB10 Moving from Data Collection to Data Visualization and Analytics: Leveraging CDISC SDTM Standards to Support Data Marts Steve Kirby, JD, MS, Chiltern, King of Prussia,
More informationCUSTOMER ATTAINMENT FROM EVENT ENGAGEMENT. EXECUTIVE SUMMARY April 2013
CUSTOMER ATTAINMENT FROM EVENT ENGAGEMENT EXECUTIVE SUMMARY April 2013 Copyright CMO Council. All Rights Reserved. 2013 ABSTRACT Change and transformation have become common occurrences if not required
More informationWhite. Paper. EMC Isilon: A Scalable Storage Platform for Big Data. April 2014
White Paper EMC Isilon: A Scalable Storage Platform for Big Data By Nik Rouda, Senior Analyst and Terri McClure, Senior Analyst April 2014 This ESG White Paper was commissioned by EMC Isilon and is distributed
More informationReduce Trial Costs While Increasing Study Speed and Data Quality with Oracle Siebel CTMS Cloud Service
Reduce Trial Costs While Increasing Study Speed and Data Quality with Oracle Siebel CTMS Cloud Service Comprehensive Enterprise Trial Management in the Cloud Oracle Siebel CTMS Cloud Service lets you effectively
More informationPaper DM10 SAS & Clinical Data Repository Karthikeyan Chidambaram
Paper DM10 SAS & Clinical Data Repository Karthikeyan Chidambaram Cognizant Technology Solutions, Newbury Park, CA Clinical Data Repository (CDR) Drug development lifecycle consumes a lot of time, money
More informationOvercoming Obstacles to Retail Supply Chain Efficiency and Vendor Compliance
Overcoming Obstacles to Retail Supply Chain Efficiency and Vendor Compliance 0 GreenLionDigital.com How process automation, data integration and visibility, advanced analytics, and collaboration improve
More informationClinical Data Management is involved in all aspects of processing the clinical data, working with a range of computer applications / database systems
Clinical Data Management is involved in all aspects of processing the clinical data, working with a range of computer applications / database systems to support collection, cleaning and management of subject
More informationperspective Progressive Organization
perspective Progressive Organization Progressive organization Owing to rapid changes in today s digital world, the data landscape is constantly shifting and creating new complexities. Today, organizations
More informationKCR Data Management: Designed for Full Data Transparency
KCR Data Management: Designed for Full Data Transparency 6% Observational 4% Phase IV 2% Device 11% Phase I 28% Phase II 49% Phase III The quality of study data relies first and foremost on the quality
More informationClinical Data Management BPaaS Approach HCL Technologies
Leading pharmaceutical companies are estimating new business models including alternative Clinical data management platforms to reduce costs, shorten timelines, and maintain quality and compliance. HCL
More informationORACLE HEALTH SCIENCES INFORM ADVANCED MOLECULAR ANALYTICS
ORACLE HEALTH SCIENCES INFORM ADVANCED MOLECULAR ANALYTICS INCORPORATE GENOMIC DATA INTO CLINICAL R&D KEY BENEFITS Enable more targeted, biomarker-driven clinical trials Improves efficiencies, compressing
More informationNormalized EditChecks Automated Tracking (N.E.A.T.) A SAS solution to improve clinical data cleaning
Normalized EditChecks Automated Tracking (N.E.A.T.) A SAS solution to improve clinical data cleaning Frank Fan, Clinovo, Sunnyvale, CA Ale Gicqueau, Clinovo, Sunnyvale, CA WUSS 2010 annual conference November
More informationDelivering Customer Value Faster With Big Data Analytics
Delivering Customer Value Faster With Big Data Analytics Tackle the challenges of Big Data and real-time analytics with a cloud-based Decision Management Ecosystem James Taylor CEO Customer data is more
More informationPRIME DIMENSIONS. Revealing insights. Shaping the future.
PRIME DIMENSIONS Revealing insights. Shaping the future. Service Offering Prime Dimensions offers expertise in the processes, tools, and techniques associated with: Data Management Business Intelligence
More informationA Model for Centralized Monitoring & Clinical Data Management Reducing costs while ensuring compliance, risk mitigation & quality
A Model for Centralized Monitoring & Clinical Data Management Reducing costs while ensuring compliance, risk mitigation & quality Dr Michael J. Klein Regional Head & Vice President Quintiles Sub-Saharan
More informationPatient Centric Monitoring Methodology
Patient Centric Monitoring Methodology The ICON approach to risk based monitoring in clinical trials An ICON White Paper Introduction The pharmaceutical and CRO industries are undergoing a radical shift
More informationHow To Write A Paper On The Clinical Trial Coding Process
WHITE PAPER Clinical Trial : Overcoming the Challenges through Automation within Electronic Data Capture Applications WHITE PAPER Abstract: This paper reviews the issues surrounding the clinical trial
More informationManaging Paper at Its Roots: Extending Beyond Document Management to Enterprise Content Compliance
Managing Paper at Its Roots: Extending Beyond Document Management to Enterprise Content Compliance Global Headquarters: 5 Speen Street Framingham, MA 01701 USA P.508.935.4445 F.508.988.7881 www.healthindustry-insights.com
More informationCapturing the Value of EDC
Capturing the Value of EDC Medidata and other marks used herein are trademarks of Medidata Solutions, Inc. All other trademarks are the property of their respective owners. Copyright 2013 Medidata Solutions,
More informationClinical Training Management
Clinical Training Management Learning and Compliance for Clinical Research Helping to Fuel the Growth of CROs and Service Providers According to clinical researcher CenterWatch, the FDA and global regulatory
More informationThe Role of the CRO in Effective Risk-Based Monitoring
New Whitepaper The Role of the CRO in Effective Risk-Based Monitoring The clinical trial industry is evolving. In an effort to improve participant safety and data integrity, regulators are encouraging
More informationIngres Insights. with Open Source Software
Ingres Insights DElivering Business intelligence with Open Source Software TABLE OF CONTENTS 3 Preface 4 Balanced Scorecards 5 Business Optimization 6 Business Intelligence (BI) 7 BI Examples 8 The Challenges
More informationClinical Investigator Cost Management
Optimizing Data and Technology in Clinical Investigator Cost Management Delivering Quantitative Value for Clinical Sponsors Related to the Cost of Drug Development Medidata and other marks used herein
More informationProject Management Office: Seeing the Whole Picture
Cloud Solutions for IT Management WHITE PAPER Project Management Office: Seeing the Whole Picture Project Portfolio Management gives PMOs the tools and techniques to get lean in lean times. Executive Summary
More informationGETTING BACK ON TRACK IN RECORD TIME: OPTIMIZING A VISUAL ANALYTICS PROGRAM AND PROCESS
GETTING BACK ON TRACK IN RECORD TIME: OPTIMIZING A VISUAL ANALYTICS PROGRAM AND PROCESS THE KEY QUESTION: How much can the power of visibility influence the decisionmaking process? The Background It s
More informationProspect of ICT Utilization at Core Clinical Research Hospitals
Prospect of ICT Utilization at Core Clinical Research Hospitals Koki Akahori One of Fujitsu s endeavors in healthcare is to develop coordinated solutions for medicine and pharmaceuticals, and is focusing
More informationAccenture Life Sciences Rethink Reshape Restructure for better patient outcomes. Accenture Accelerated R&D Services Overview
Accenture Life Sciences Rethink Reshape Restructure for better patient outcomes Accenture Accelerated R&D Services Overview 1 The first fully-integrated, technology-enabled, global business service that
More informationPerformance Management for Enterprise Applications
performance MANAGEMENT a white paper Performance Management for Enterprise Applications Improving Performance, Compliance and Cost Savings Teleran Technologies, Inc. 333A Route 46 West Fairfield, NJ 07004
More informationModern IT Operations Management. Why a New Approach is Required, and How Boundary Delivers
Modern IT Operations Management Why a New Approach is Required, and How Boundary Delivers TABLE OF CONTENTS EXECUTIVE SUMMARY 3 INTRODUCTION: CHANGING NATURE OF IT 3 WHY TRADITIONAL APPROACHES ARE FAILING
More informationUsing Cloud-Based Technologies in Clinical Trials by Niki Kutac, Director, Product Management
White Paper Using Cloud-Based Technologies in Clinical Trials by Niki Kutac, Director, Product Management Technology has transformed industries, from music to medicine. Advances in data availability and
More informationInternal Audit Practice Guide
Internal Audit Practice Guide Continuous Auditing Office of the Comptroller General, Internal Audit Sector May 2010 Table of Contents Purpose...1 Background...1 Definitions...2 Continuous Auditing Professional
More informationBusiness Intelligence and Big Data Analytics: Speeding the Cycle from Insights to Action Four Steps to More Profitable Customer Engagement
white paper Business Intelligence and Big Data Analytics: Speeding the Cycle from Insights to Action Four Steps to More Profitable Customer Engagement»» Summary For business intelligence analysts the era
More informationBuilding a Tangible ROI for Data Quality
Building a Tangible ROI for Data Quality Harte-Hanks Trillium Software www.trilliumsoftware.com Corporate Headquarters + 1 (978) 436-8900 trilinfo@trilliumsoftware.com How Do I Create a Data Quality ROI?
More informationBuilding a Data Quality Scorecard for Operational Data Governance
Building a Data Quality Scorecard for Operational Data Governance A White Paper by David Loshin WHITE PAPER Table of Contents Introduction.... 1 Establishing Business Objectives.... 1 Business Drivers...
More informationWhite Paper. Technology Spotlight: Adoption of Clinical Trial Management Systems for Investigator Selection and Site Monitoring
ArisGlobal White Paper Technology Spotlight: Adoption of Clinical Trial Management Systems for Investigator Selection and Site Monitoring 2013 ArisGlobal LLC. All rights reserved. WP-CR-ISSM0913. ARISg,
More informationLeveraging data analytics and continuous auditing processes for improved audit planning, effectiveness, and efficiency. kpmg.com
Leveraging data analytics and continuous auditing processes for improved audit planning, effectiveness, and efficiency kpmg.com Leveraging data analytics and continuous auditing processes 1 Executive
More informationOptimizing Quality Control / Quality Assurance Agents of a Global Sourcing / Procurement Strategy
Optimizing Quality Control / Quality Assurance Agents of a Global Sourcing / Procurement Strategy Global Pharma Sourcing Conference December 6-7, 2011 Philadelphia, USA Nigel J. Smart, Ph.D. Smart Consulting
More informationDelivering Business Intelligence with Open Source Software
Delivering Business Intelligence with Open Source Software WHITE PAPER by Chip Nickolett, Ingres Corporation Ingres Business Intelligence Series Table of Contents Preface...3 Balanced Scorecards...4 Business
More informationNeeds, Providing Solutions
Identifying Needs, Providing Solutions 1 I n d u s t r y The growth of medical research and the countless innovations coming from the pharmaceutical, biotechnology and medical device industry, has improved
More informationBETTER BUSINESS FORESIGHT THROUGH SHARPER TECHNOLOGICAL INSIGHT.
www.wipro.com BETTER BUSINESS FORESIGHT THROUGH SHARPER TECHNOLOGICAL INSIGHT. FixOmatic DO BUSINESS BETTER AUTOMATION: THE KEY TO SERVICE INNOVATION Automation has now become one of the top priorities
More informationLean manufacturing in the age of the Industrial Internet
Lean manufacturing in the age of the Industrial Internet From Henry Ford s moving assembly line to Taiichi Ohno s Toyota production system, now known as lean production, manufacturers globally have constantly
More informationPosition Paper: Risk-Based Monitoring Methodology
Position Paper: Risk-Based Monitoring Methodology 1. Abstract Current On-site Monitoring practices are frequency-based, conform to a prescribed monitoring visit schedule, and provide generalized quality
More informationWe are used to the idea of measurement in the general practice of
This article describes some key considerations for organizations as they review their approach to metrics or as they begin developing a key set of metrics. Keith Dorricott, BSc Using Metrics to Direct
More informationMDM Approach for EVMPD & IDMP Compliance
MDM Approach for EVMPD & IDMP Compliance Monica McDonnell November 13 th, 2014 Agenda Why a MDM Approach for IDMP Compliance? Benefits of a MDM Approach to IDMP The History Behind IDMP EVMPD has required
More informationOptimizing Data Validation!
Paper DH03 Optimizing Data Validation! Andrew Newbigging, Medidata Solutions Worldwide, London, United Kingdom ABSTRACT Much effort goes into the specification, development, testing and verification of
More informationWhite Paper March 2009. Government performance management Set goals, drive accountability and improve outcomes
White Paper March 2009 Government performance management Set goals, drive accountability and improve outcomes 2 Contents 3 Business problems Why performance management? 4 Business drivers 6 The solution
More informationwith Managing RSA the Lifecycle of Key Manager RSA Streamlining Security Operations Data Loss Prevention Solutions RSA Solution Brief
RSA Solution Brief Streamlining Security Operations with Managing RSA the Lifecycle of Data Loss Prevention and Encryption RSA envision Keys with Solutions RSA Key Manager RSA Solution Brief 1 Who is asking
More informationQuality Monitoring Checklist
Quality Monitoring Checklist Instructions: For each task below, the Quality Monitor indicates in the appropriate column if the Monitor accomplished the task by using the following codes Yes No N/A = Monitor
More informationFormulate Winning Sales and Operations Strategies Through Integrated Planning
SAP Brief SAP Supply Chain Management SAP Sales and Operations Planning Objectives Formulate Winning Sales and Operations Strategies Through Integrated Planning Keep pace with rapidly changing market conditions
More informationIdentifying Cloud Management Options for Increased Security, Efficiency and Reliability
White Paper Cloud vs. Managed Cloud Identifying Cloud Management Options for Increased Security, Efficiency and Reliability Introduction Today, enterprises of all sizes are leveraging cloud computing in
More informationWHITE PAPER > Situational Management for SOA
WHITE PAPER > Situational Management for SOA Published by: P/02 EXECUTIVE SUMMARY P/03 SITUATIONAL MANAGEMENT FOR SOA P/04 SITUATIONAL MANAGEMENT FOR SOA WITH AUTO PILOT M6 P/07 CONCLUSION EXECUTIVE SUMMARY
More informationThe Sophos Security Heartbeat:
The Sophos Security Heartbeat: Enabling Synchronized Security Today organizations deploy multiple layers of security to provide what they perceive as best protection ; a defense-in-depth approach that
More informationTIBCO Live Datamart: Push-Based Real-Time Analytics
TIBCO Live Datamart: Push-Based Real-Time Analytics ABSTRACT TIBCO Live Datamart is a new approach to real-time analytics and data warehousing for environments where large volumes of data require a management
More informationTaking the Migraine Out of Migrations
Taking the Migraine Out of Migrations In our recent meeting with a senior IT executive, she shared that she accepted her current position a few years ago with the caveat, I ll do anything except data migrations.
More informationStreamlining the Flow of Clinical Trial Data: EHR to EDC to Sponsor
Streamlining the Flow of Clinical Trial : EHR to EDC to Sponsor Landen Bain Liaison to Healthcare CDISC Interchange Standards Consortium) Jane Griffin, RPh Director, Pharmaceutical Research Cerner Corporation
More informationIBM Business Analytics: Finance and Integrated Risk Management (FIRM) solution
IBM Sales and Distribution Solution Brief Banking IBM Business Analytics: Finance and Integrated Risk Management (FIRM) solution Risk transparency across the enterprise 2 IBM Business Analytics: Finance
More informationData as a Service Virtualization with Enzo Unified
Data as a Service Virtualization with Enzo Unified White Paper by Blue Syntax Abstract: This white paper explains how companies can benefit from a Data as a Service virtualization layer and build a data
More informationOracle Health Sciences Suite of Life Sciences Solutions
Oracle Health Sciences Suite of Life Sciences Solutions Integrated Solutions for Global Clinical Trials Oracle Health Sciences provides the world s broadest set of integrated life sciences solutions, enabling
More information